Burkitt's Onion (Allium cepa 'Burkitt')

Burkitt's Onion (Allium cepa 'Burkitt') is a specialized onion variety containing high concentrations of quercetin-3,4'-diglucoside (171.34 μg/g) and organosulfur compounds. These bioactive compounds provide antioxidant activity through free radical scavenging mechanisms.

Origin & History

Burkitt's Onion (Allium cepa 'Burkitt') is a cultivar of the common onion from the Amaryllidaceae family, originating from central Asia and cultivated for over 5,000 years. The bulb contains flavonoids and organosulfur compounds typically extracted using methanol or ethanol for phytochemical analysis via HPLC.

Historical & Cultural Context

Allium cepa has been used for millennia in traditional medicine systems including Ayurveda and European herbalism for digestive issues, wounds, and as an antimicrobial agent. The specific 'Burkitt' cultivar's traditional use is not documented in available sources.

Health Benefits

• Antioxidant activity demonstrated in vitro with 64.82% DPPH inhibition at 100 μg/mL (preliminary evidence only)
• Rich source of quercetin derivatives (171.34 μg/g quercetin-3,4′-diglucoside) supporting potential anti-inflammatory effects (no human studies available)
• Contains organosulfur compounds like allicin traditionally associated with cardiovascular support (clinical evidence lacking)
• Provides anthocyanins including peonidin and petunidin glucosides with potential cellular protection (in vitro data only)
• Traditional antimicrobial applications supported by phytochemical profile (no controlled trials identified)

How It Works

Burkitt's Onion's primary bioactive compound, quercetin-3,4'-diglucoside, acts as an antioxidant by donating electrons to neutralize free radicals and inhibiting lipid peroxidation. The organosulfur compounds modulate inflammatory pathways by inhibiting pro-inflammatory enzymes like cyclooxygenase and lipoxygenase. These mechanisms work synergistically to reduce oxidative stress and inflammatory markers at the cellular level.

Scientific Research

No human clinical trials, RCTs, or meta-analyses for Allium cepa 'Burkitt' or general Allium cepa focused on biomedical outcomes were identified in the research. Available evidence is limited to preclinical phytochemical characterization and in vitro antioxidant assays (DPPH 64.82% inhibition, ORAC 17.62 µmol TE/mL at 100 μg/mL).

Clinical Summary

Research on Burkitt's Onion is limited to preliminary in vitro studies demonstrating 64.82% DPPH radical scavenging activity at 100 μg/mL concentration. Laboratory analysis has confirmed high quercetin-3,4'-diglucoside content at 171.34 μg/g, suggesting potential anti-inflammatory properties. No human clinical trials or animal studies have been conducted to validate these preliminary findings. Current evidence is insufficient to support therapeutic claims.

Nutritional Profile

Burkitt's Onion (Allium cepa 'Burkitt') shares the foundational nutritional composition of common onion cultivars with cultivar-specific phytochemical distinctions. Macronutrient profile per 100g fresh weight (estimated from Allium cepa baseline): carbohydrates ~9.3g (predominantly fructooligosaccharides and fructose), dietary fiber ~1.7g (inulin-type fructans supporting prebiotic activity), protein ~1.1g (limited essential amino acid completeness), fat ~0.1g, water ~89g, energy ~40 kcal. Micronutrients include vitamin C (~7.4mg/100g, though cultivar variance may alter this), vitamin B6 (pyridoxine ~0.12mg/100g), folate (~19μg/100g), potassium (~146mg/100g), calcium (~23mg/100g), phosphorus (~29mg/100g), and manganese (~0.13mg/100g). Notably elevated flavonoid content distinguishes this cultivar: quercetin-3,4′-diglucoside measured at 171.34 μg/g fresh weight, a glycosylated form with moderate bioavailability — intestinal deglycosylation by lactase phlorizin hydrolase is required before absorption, reducing effective bioavailability compared to aglycone quercetin. Total flavonol content likely ranges 200–350 μg/g based on related cultivars. Organosulfur compounds including alliin (~0.5–1.0mg/g), converted enzymatically to allicin upon tissue disruption; allicin is volatile and degrades rapidly during cooking, substantially reducing bioavailable concentration. Fructooligosaccharide content (~2–6g/100g dry weight) supports colonic fermentation. Chromium trace levels (~0.006mg/100g) noted in onion genus broadly. Bioavailability note: quercetin glycosides from onion matrix show approximately 52–65% relative bioavailability in human gut models compared to pure aglycone standards; food matrix effects (fiber, co-ingested fat) modestly enhance micellarization of lipophilic flavonoids.

Preparation & Dosage

No clinically studied dosage ranges are available for any form of Allium cepa (extract, powder, or standardized preparations). In vitro studies used concentrations of 100 μg/mL for antioxidant assays, but human dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Garlic extract, Turmeric, Green tea extract, Vitamin C, Resveratrol

Safety & Interactions

Burkitt's Onion is generally recognized as safe when consumed as food, but concentrated supplements lack safety data. Individuals taking anticoagulant medications should exercise caution due to potential bleeding risk from organosulfur compounds. Those with existing onion allergies or GERD may experience digestive irritation or allergic reactions. Safety during pregnancy and lactation has not been established for supplemental forms.